Sign In
Buy SOPH
$5.23
-0.110 (-2.06%)
At Close: Jun 23, 2026
SOPHiA GENETICS Publishes Results of the 2026 Annual General Meeting
08:25am, Monday, 22'nd Jun 2026
Shareholders adopt all proposals, co-founder Dr. Jurgi Camblong elected as Executive Chairman of the Board, Ross Muken elected as new member of the Board ahead of his appointment as CEO effective July
BOSTON and ROLLE, Switzerland, June 19, 2026 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a global leader in Ai-driven precision medicine, announced today the closing of its previously announced un
SOPHiA Genetics: Strong Growth Meets A Critical Execution Phase
08:22am, Thursday, 18'th Jun 2026
SOPHiA GENETICS is approaching an inflection point in precision medicine, leveraging AI-driven genomic analysis as sequencing costs decline and data complexity rises. SOPH's platform benefits from a s
Sophia Genetics, Ormat Technologies And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
08:03am, Wednesday, 17'th Jun 2026
U.S. stock futures were mostly higher this morning, with the Nasdaq futures gaining over 100 points on Wednesday.
SOPHiA GENETICS Announces Pricing of $50 Million Public Offering of Ordinary Shares
10:00pm, Tuesday, 16'th Jun 2026
SOPHiA GENETICS Announces Pricing of $50 Million Public Offering of Ordinary Shares PR Newswire BOSTON and ROLLE
SOPHiA GENETICS Announces Pricing of $50 Million Public Offering of Ordinary Shares
09:21pm, Tuesday, 16'th Jun 2026
BOSTON and ROLLE, Switzerland, June 16, 2026 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a global leader in Ai-driven precision medicine, announced today the pricing of its previously announced un
SOPHiA GENETICS Announces Proposed Public Offering of Ordinary Shares
04:20pm, Tuesday, 16'th Jun 2026
BOSTON and ROLLE, Switzerland, June 16, 2026 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a global leader in Ai-driven precision medicine, announced today the commencement of a proposed underwrit
SOPHiA GENETICS Confirms Leadership Transition Ahead of 2026 Annual General Meeting
08:00am, Wednesday, 10'th Jun 2026
Ross Muken to assume the role of Chief Executive Officer effective July 1, 2026; Co-founder Dr. Jurgi Camblong nominated for election as Chairman of the Board BOSTON and ROLLE, Switzerland, June 10, 2
SOPHiA GENETICS Signs Strategic Collaboration MOU with Leading Global Cancer Center
08:00am, Thursday, 04'th Jun 2026
SOPHiA GENETICS and Memorial Sloan Kettering Cancer Center Aim to Establish Precision Medicine Hub for the Next Generation of Precision Oncology NEW YORK, June 4, 2026 /PRNewswire/ -- SOPHiA GENETICS
Synnovis and SOPHiA GENETICS Partner to Bring Blood-based Cancer Testing to Patients Across the U.K.
06:00am, Wednesday, 13'th May 2026
Synnovis and SOPHiA GENETICS Partner to Bring Blood-based Cancer Testing to Patients Across the U.K. PR Newswire
Synnovis and SOPHiA GENETICS Partner to Bring Blood-based Cancer Testing to Patients Across the U.K.
05:00am, Wednesday, 13'th May 2026
LONDON, May 13, 2026 /PRNewswire/ -- SOPHiA GENETICS (NASDAQ: SOPH), a global leader in Ai-driven precision medicine, today announced a partnership with Synnovis, one of England's leading pathology p
SOPHiA GENETICS SA (SOPH) Q1 2026 Earnings Call Transcript
02:31pm, Tuesday, 05'th May 2026
SOPHiA GENETICS SA (SOPH) Q1 2026 Earnings Call Transcript
SOPHiA GENETICS Reports First Quarter 2026 Results
06:45am, Tuesday, 05'th May 2026
BOSTON and ROLLE, Switzerland, May 5, 2026 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a global leader in Ai-driven precision medicine, today reported financial results for the first quarter ended
SOPHiA GENETICS to Announce Financial Results for First Quarter 2026 on May 5, 2026
08:00am, Tuesday, 21'st Apr 2026
BOSTON and ROLLE, Switzerland, April 21, 2026 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a global leader in AI-driven precision medicine, today announced it will release its financial results for
Mount Sinai Health System and SOPHiA GENETICS Announce Collaboration to Advance Precision Cancer Care from AACR 2026
08:00am, Thursday, 16'th Apr 2026
SAN DIEGO and NEW YORK, April 16, 2026 /PRNewswire/ -- SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, today announced that the Mount Sinai Health System, one of the
